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Rigorous phylogenetic analyses were used to compare the nucleotide sequences of feline immunodeficiency
virus strains isolated from Texas and throughout the world. The envelope V3-V4 sequences and capsid gene of
the Texas isolates formed a cluster between subtypes B and E. Statistical comparisons with other published
sequences confirmed that the Texas group is a unique cluster, possibly a new subtype, arising from subtype B.
capsid gene of the new Texas FIV strains and to compare those
sequences with existing sequences of other FIV strains.
Feline peripheral blood mononuclear cells (PBMCs) were
isolated from EDTA (K3)-treated whole-blood samples by
Histopaque-1077 (Sigma Chemicals, St. Louis, Mo.) density
gradient centrifugation. PBMCs were grown ex vivo for 7 to 10
days as previously described (27). Cells were grown at 37°C in
a humidified atmosphere containing 5% CO2, with a change of
medium every 3 to 4 days. FIV replication in the culture was
determined by detection of capsid antigen in the supernatants
with an antigen capture enzyme-linked immunosorbent assay
(IDEXX, Portland, Maine) as described elsewhere (25).
Total RNA was extracted (using TRIzol reagent [Invitrogen,
Carlsbad, Calif.]) from virus-infected PBMCs and stored at
⫺70°C. Viral cDNA was synthesized using SuperScript II
RNase H reverse transcriptase (Invitrogen) primed with oligo(dT). The V3-V4 sequence and capsid gene were separately
amplified by nested PCR. For the V3-V4 sequence, the primary PCR used primers 6785F (5⬘-GCG CAA GTA GTG
TGG AG-3⬘) and 8842R (5⬘-GCT TCA TCA TTC CTC CTC
TT-3⬘); the nested, secondary amplification employed primers
7316F (5⬘-ATA CCA AAA TGT GGA TGG TG-3⬘) and
7866R (5⬘-CAA GAC CAA TTT CCA GCA AT-3⬘). The
following two sets of primers were used for amplifying the
capsid genes: 1053F (5⬘-GAA GAT CTC ATG GGG AAC
GGA CAG GGG CGA-3⬘) and 2403R (5⬘-GTC GAC TTA
TAA ATC CAA TAG TCT CTC CTC-3⬘) for the primary
PCR and 1458F (5⬘-GAA GAT CTC CCT ATT CAA ACA
GCA AAT GGA GCA-3⬘) and 2127R (5⬘-CCA TCG ATG
GCA AGA GTT GCA TTT TAT ATC CTG G-3⬘) for the
nested, secondary PCR. Primary reactions (50 l) contained
100 ng of cDNA, a 100 nM concentration of each primer, 200
M concentrations of each of the four deoxynucleoside
triphosphates, and 1.5 U of TaqDNA polymerase. After incubating at 94°C for 5 min, reactions were subjected to five cycles
of amplification at 94°C for 60 s, 53°C for 60 s, and 72°C for 2
min, an additional 30 cycles at 94°C for 15 s and 53°C for 15 s
(with a 0.1°C increase after each cycle), and 72°C for 2 min,
which was followed by 72°C for 15 min of incubation to ensure
the completion of elongation. The same conditions and parameters were applied to the second set of amplifications, except
that 10 l of each of the primary PCR products was used as a

Feline immunodeficiency virus (FIV) was initially isolated in
1987 from a cat in California with severe immunodeficiency
and has been recognized as a common worldwide feline pathogen (11, 14, 19, 20, 33). FIV-infected cats exhibit a progressive
impairment of cellular immunity, leaving the animals susceptible to opportunistic infections (17, 23, 24). Similar to other
lentiviruses, genetic variations may occur as a result of point
mutations or recombination (1, 2). Since genetic variation and
associated disease characteristics are similar between FIV and
human immunodeficiency virus, FIV is a practical model for
T-tropic lentiviral infection, especially for vaccine development and the design of antiviral therapies (3, 4, 11, 12, 14, 17,
21, 27, 29, 33, 34).
A number of FIV strains have been identified throughout
the world, and their corresponding genomes have been partially sequenced (1, 5, 6, 10, 13, 15, 18, 19, 22, 27, 32). Studies
developed on the basis of the nucleotide sequences from the
envelope gene separated FIV strains into five distinct phylogenetic subtypes designated A to E (1, 2, 10, 13, 22, 27).
Although geographic isolation could be a major factor in the
evolution of FIV, individual subtypes are found in more than
one part of the world (1, 2, 5, 13, 19, 27). For example, subtypes
A and B have been isolated from cats in the United States,
Europe, Japan, and Australia, and subtype C-infected cats
have been identified in North America, Europe, and Taiwan.
Consequently, recombinant strains have also been described
(notably between subtype A and B subtypes and between B
and D subtypes) (1, 2). The isolation and characterization of
new FIV isolates with a broad feline representation, including
high-risk feral cats, are critical for better understanding of
ongoing genetic diversity.
In the present study, FIV was isolated from 11 feral cats that
were trapped by the Aggie Feral Cat Alliance in Brazos
County, Tex., and surrounding areas. Rigorous phylogenetic
analyses were used to determine nucleotide sequences from
the V3-V4 region of the envelope gene and from the whole
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template. The PCR products were purified using a Genelute
PCR clean-up kit (Sigma Chemical Co.) and directly used as
templates for DNA sequencing using a dye terminator method
(Gene Technologies Core Facility, Texas A&M University).
Phylogenetic relationships of these new isolates were inferred from analyses of the V3-V4 and capsid sequences (7).
To determine the relationships of the V3-V4 region, nucleotide sequences from 11 Texas isolates were aligned with 43
homologues retrieved (using a MacVector v7.0 program [Genetics Computer Group, Madison, Wis]) from the GenBank
database. All aligned sequences were also inspected manually.
Positions containing gaps or ambiguously aligned positions
were removed from the data set. Finally, a total of 501 nucleotide (nt) positions from 54 taxa that can be unambiguously
aligned by codons were included in the final phylogenetic analyses. Similarly, DNA sequences of capsid genes from 27 isolates (including 7 Texas isolates) were aligned; a total of 606 nt
positions were used for phylogenetic reconstructions.
Phylogenetic analyses were performed using Bayesian inference (BI), maximum likelihood (ML), and maximum parsimony (MP) approaches for both V3-V4 and capsid datasets.
For BI phylogeny, nucleotide sequences were partitioned by
codons. The MrBayes v3.0 program (9) was used to perform a
total of 1,000,000 generations of searches with a Markov chain
Monte Carlo sampling method with four chains simultaneously
running. Start trees for all chains were randomly generated by
the MrBayes program. Posterior possibility (PP) values were
obtained using an extended majority ruling method to calculate the consensus tree from the best BI trees. ML analysis
employed a quartet-puzzling method using a HKY85 nucleotide substitution model with the consideration of two rates of
heterogeneity (one invariable plus one variable). Best quartetlikelihood trees were constructed using the Treepuzzle v5.0
program with 1,000 puzzling steps (30). All parameters, including transition-transversion ratio, nucleotide frequency, and
fraction of invariable sites, were estimated from the datasets
on the basis of neighbor-joining topologies. For MP bootstrapping analysis, a full heuristic algorithm and the PAUP* v4.0b10
program (31) were used to search for the best trees from 1,000
replicates. Sequences were added randomly, and tree-bisection
reconnection was applied for branch swapping during the MP
tree searches.
During BI analysis, the best-likelihood values were reached
before 40,000 generations of Markov chain Monte Carlo
searches for both ENV-V3-V4 and the capsid datasets, indicating that 1,000,000 generations were sufficient for the chains.
The BI consensus trees inferred from all alignments clearly
separated FIV viral strains into six major clusters, five of which
were the previously established subtypes (i.e., A, B, C, D, and
E); the sixth cluster consisted of the 11 newly cloned Texas
(TX) isolates plus the previously reported Txmtex03 strain
(Fig. 1 and 2). The separation of these major subtypes and the
cluster was robustly supported by the PP values (i.e., PP in all
major nodes ⫽ 97 to 100%). The branch lengths between the
B subtype and the Texas cluster were better separated in
V3-V4 trees than in the capsid gene trees. The B subtype and
Texas cluster are clearly related to each other, indicating that
these two clusters evolved from a common FIV viral ancestor.
When the two alignments were subjected to the quartet-puzzling ML and MP analyses, both methods again divided all viral
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isolates into six major clusters. However, relationships of isolates among these major FIV clusters were not well resolved by
quartet likelihood and MP analyses (Fig. 1 and 2; collapsed
branches in ML/MP analyses are marked by an x). In all trees,
the ML puzzling indices and MP bootstrapping supporting
values were lower than the BI PP values at corresponding
nodes with both puzzling and bootstrapping methods (indicative of rapidly evolving genomes), suggesting an overconservative nature.
To further validate these observations with a more extensive
region, the capsid data set was fused with corresponding
V3-V4 sequences to form a large data set containing 1,107 nt
positions. Such concatenated sequences included more phylogenetic informative positions for tree constructions than individual sequences. Upon phylogenetic analysis using the BI
method, the same six clusters were formed as in the previous
trees (Fig. 2). Again, Texas isolates clustered to a unique
branch between the B and E clades. All major clade findings
were 100% supported by the PP analysis. The fused data set
also improved the resolution of the tree and statistically supported values for the quartet likelihood and MP analyses,
though a few major nodes were still unsolved by ML and/or
MP analyses (marked by an x in Fig. 2).
The divergence of Texas strains (as a unique cluster) from
subtype B viruses was also confirmed by the genetic distances
of the V3-V4 regions. The means of the distances of the FIV
isolates within and among various subtypes were calculated
using a Jukes-Cantor method (Table 1). The results revealed
that the Texas cluster was most divergent from subtype A and
least divergent from subtype B. The genetic distances between
sequences of isolates within the Texas group (mean of distances ⫽ 6.4) were similar to those of subtype B (i.e., 6.2),
which were less than those within subtypes A and C (i.e., 10.1)
but more than those within subtypes D and E (i.e., 4.4 to 4.9).
Although double-crossover events could have occurred in regions not sequenced to maintain the observed coevolution of
V3-V4 and the capsid sequences, genetic shifts were not identified and the similarities were maintained. Therefore, observed divergence would seem to have occurred through point
mutations rather than recombination (1, 2).
Our data clearly indicate that FIV strains within the United
States are much more divergent than initially thought. The
Texas cluster is apparently distinct from subtype B viruses,
suggesting the presence or emergence of a possible new FIV
subtype in the United States. The Texas cluster and the B
subtype were more closely related than the others, indicating
that the two could have evolved from a common ancestor. The
original isolate from Texas (TXmtex03) was, in fact, classified
as a subtype B isolate in the absence of other isolates. The
sequences of additional isolates allowed for more accurate
phylogenetic analysis of this group of FIV strains. Conclusive
evidence that the Texas cluster indeed represents a new FIV
subtype may depend on immunological studies and sequencing
analyses of additional genes and additional isolates. Nonetheless, the divergence of this Texas cluster from subtype B was
evident. At the least, a parsimonious explanation is that these
Texas FIV isolates may represent a distinct subgroup within
the subtype B.
The divergence of FIV in the United States raises broader
questions relative to vaccine design (1, 4). Although the only
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FIG. 2. Phylogenetic tree determined on the basis of the concatenated V3-V4 and capsid sequences (total positions ⫽ 1,107 nt). Statistically
supporting values, which included PP values (BI [from 9,000 best trees]), bootstrapping proportions (MP [from 1,000 replicates]), and puzzling
indices (ML [with 10,000 puzzling steps]), are again shown at major branches. Collapsed branches determined by MP and/or ML analysis are
marked by an x at corresponding positions. The GenBank accession numbers are listed in the legend for Fig. 1.

FIG. 1. (A) Phylogenetic relationships among 54 FIV isolates determined (using BI, MP, and quartet-puzzling methods) on the basis of
envelope V3-V4 region nucleotide sequences. A total of 501 nt positions were included for the tree reconstructions. The tree shown here is a
consensus tree calculated from the best 9,000 BI trees. Statistical supporting values shown at major branches are PP (BI [from 9,000 best trees]),
bootstrapping proportions (MP [from 1,000 replicates]), and puzzling indices (ML [with 10,000 puzzling steps]). Collapsed (unsupported) branches
(as determined by MP and/or ML analysis) are marked by an x at corresponding positions. The strain names (GenBank accession numbers) for
the V3-V4 sequences are as follows: EngUK8 (X69496); ScotUK2 (X69494); Wales UK14 (X69497); Wo (L06312); Dutch19K32 (M73965);
USCAzepy01A (U02417); USCAhnky12A (U02403); USCAsam01A (U02410); USCAtt09A (U02413); SAP03 (AB010404); Sendai2 (D37814);
Aomori 2 (D37817); Aomori 1 (D37816); Yokohama (D37812); AICO2 (AB010397); TY1 (D67064); USMAboy03B (U02419); USILbrny03B
(U02418); USMOglwd03B (U02420); USTXmtex03B (U02422); M88 (Y13868); M2 (X69501); M3 (X69502); Lp9 (D84497); CABCpady02C
(U02392); CABCpbar02C (U02394); CABCpbar03C (U02395); CABCpbar01C (U02393); CABCpbar07C (U02397); DEBAfredC (U57020); TI1
(AB016025); TI2 (AB016026); TI3 (AB016027); TI4 (AB016028); Fukuoka (D37815); Shizuoka (D37811); OKA01D (AB010400); Lp3 (D84496);
Lp20 (D84498); Lp24 (D84500); TM2 (M59418); Usil2489_7B (U11820); Petaluma (M25381); PPR (M36968): TX125 (AY139094); TX120
(AY139095); TX200 (AY139096); TXMK (AY139097); TX133 (AY139098); TX132(AY139099); TX84 (AY139100); TXTG (AY139101); TX78
(AY139102); TX109 (AY139102); and TX77 (AY139103). (B) Consensus BI tree inferred from 27 capsid gene sequences with a total of 606 nt
positions. PP values (BI [from 9,000 best trees]), bootstrapping proportions (MP [from 1,000 replicates]), and puzzling indices (ML [with 10,000
puzzling steps]) are shown at major branches. Collapsed branches (as determined by MP and/or ML analysis) are marked by an x at corresponding
positions. The strain names (GenBank accession numbers) for the capsid sequences are as follows: Wo (L06136); Sendai1 (D37820); Z1 (X57001);
Aomori2 (D37824); Sendai2 (D37821); Yokohama (D37819); Aomori1 (D37820); ItM3 (Y13866); ItM2 (Y13867); TI3 (AB027300); TI4
(AB027301); TI2 (AB027299); TI1 (AB027298); Shizuoka (D37822); Fukuoka (D37818); Lp24 (AB027304); Lp20 (AB027303); Lp3 (AB027302);
TM2 (M59418); Usil2489_7B (U11820); Petaluma (M25381); PPR (M36968); TX120 (AY139105); TX77 (AY139106); TX78 (AY139107); TX84
(AY139108); TX53 (AY139109); TX200 (AY139110); TXTG (AY139111); and TX132 (AY139112).
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TABLE 1. Means of Jukes-Cantor distances between isolates within
and among various subtypesa
Subtype

A
B
C
D
E
TX

Results (genetic distance) for subtypeb:
A

B

C

D

10.10
23.16
23.95
22.60
23.37
23.83

6.19
22.82
18.29
17.78
15.07

10.33
23.36
23.97
23.40

4.88
18.78
21.58

E

TX

11.
12.

13.

4.39
18.04

6.37

14.

Kimura three-parameter and general time-reversal analyses provided similar
results and confirmed the relationships.
b
The similar comparison results represent distances within each subtype or
cluster.

15.

a

commercial vaccine for FIV is comprised of subtypes A and D
viruses, this vaccine may not be effective against natural challenge strains (12, 29). While there are no reports of significant
differences in the biological impact of FIV isolated from Texas,
the phylogenetic analyses presented in this study suggested
that a possible new subtype (or subtype cluster) should be
taken into consideration, especially with regard to vaccine design and testing. The amount of variation within the United
States warrants additional ongoing comprehensive analyses to
truly understand the breadth of FIV diversity throughout the
world.
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